Osteoboost raises $8m to scale bone wearable
Osteoboost Health has secured **$8 million** in funding to enhance the manufacturing and research of its FDA-cleared wearable device designed to combat **osteop...
The whole archive, filed by the part of life it belongs to — and labelled with how strong the evidence behind it actually is.
Showing 2329–2352 of 3,535
Osteoboost Health has secured **$8 million** in funding to enhance the manufacturing and research of its FDA-cleared wearable device designed to combat **osteop...
The **Centers for Medicare & Medicaid Services (CMS)** is launching a **Medicare App Library** designed to simplify access to health data for beneficiaries, wit...
Stiltz Homelifts has launched its first U.S. showroom in Denver, a strategic move aimed at enhancing accessibility solutions for aging populations and individua...
Researchers have established a **causal link between the chemokine CXCL9 and accelerated epigenetic aging**, as measured by the GrimAge clock, in a recent study...
Tim Gray's recent insights on biohacking reveal a pivotal shift in the field, emphasizing **optimization through subtraction** rather than addition. In the late...
**Edelman’s Longevity Lab** is spearheading a pivotal shift in brand strategy with its upcoming **preview breakfast** on April 28, 2024, in London, aimed at add...
bioMérieux has published a groundbreaking health economic analysis demonstrating that early deployment of **fast identification and antimicrobial susceptibility...
bioMérieux has released a groundbreaking international economic analysis demonstrating that early use of rapid identification and antibiotic susceptibility test...
Allsup Employment Services (AES) is advocating for the utilization of **federal tax incentives** as a strategic approach for employers to enhance workforce incl...
**ONWARD Medical N.V.** has successfully closed a **€40.6 million** private placement with institutional investors, enhancing its capacity to develop innovative...
The **Naomi Ruth Cohen Institute for Mental Health Education** (NRCI) has announced its 24th Annual Community Mental Health Conference titled **"Alone Together:...
The global vascular access device market is poised for significant growth, projected to expand from **USD 6.27 billion in 2026 to USD 8.68 billion by 2031**, re...
AlayaCare has announced a strategic partnership with Eitan Medical to integrate Eitan Insights™, a cloud-based digital health solution, with AlayaCare’s existin...
BVI has achieved CE Mark certification for its **Virtuoso®** dual-function phaco-vitrectomy platform, designed to enhance control and efficiency in both catarac...
BVI Medical, Inc. has announced the **CE marking** for its innovative **Virtuoso® platform**, a dual-function phaco-vitrectomy system designed to enhance surgic...
The **global medical radiation shielding market** is projected to grow from approximately **USD 1.6 billion in 2024 to USD 3.2 billion by 2034**, reflecting a *...
Intelligent Bio Solutions Inc. (INBS) has initiated a **validation study** aimed at reducing the analysis time of its **Intelligent Fingerprinting Drug Screenin...
Lilly is acquiring Kelonia to advance a new gene therapy for multiple myeloma, potentially improving treatment access and effectiveness.
Lilly has announced its acquisition of Kelonia Therapeutics, a move aimed at enhancing its capabilities in **in vivo CAR-T cell therapies**. Kelonia's lead cand...
Rpharmy has successfully completed its **SOC® 2 Type II audit**, demonstrating a robust commitment to data security in healthcare software solutions. This audit...
The **global life sciences consulting services market** is poised for substantial growth, with a projected increase from approximately **USD 14.1 billion in 202...
ENvue Medical, Inc. has announced the implementation of its **ENvue™ Navigation Platform** at a Virginia-based regional medical center, marking a significant sh...
Helus Pharma™ has responded positively to the recent White House Executive Order aimed at accelerating the research, regulatory pathways, and patient access to...
AskBio Inc. has announced the advancement of its investigational gene therapy, **ametefgene parvec (AB-1005)**, for Parkinson’s disease (PD) and multiple system...